Savara (SVRA) Other Accumulated Expenses (2012 - 2019)
Savara (SVRA) reported Other Accumulated Expenses of $5000.0 for Q2 2019, down 87.8% quarter-over-quarter from $41000.0 in Q1 2019.
Savara (SVRA) Other Accumulated Expenses (2012 - 2019) Analysis & Trends
Savara (SVRA) has 8 years of Other Accumulated Expenses data on file, last reported at $5000.0 in Q2 2019.
- Other Accumulated Expenses for Q2 2019 came in at $5000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2019 was $5000.0 (changed N/A YoY), and the FY2018 annual result was $41000.0, up 485.71% from the prior year.
- Other Accumulated Expenses fell to $5000.0 in Q2 2019 per SVRA's latest filing, from $41000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $438000.0 in Q1 2016 and troughed at $5000.0 in Q2 2019.
- A 5-year average of $204928.6 and a median of $253500.0 in 2015 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2017 and 2018: Other Accumulated Expenses tumbled 96.74% in 2017, then soared 485.71% in 2018.
- A 5-year view of Other Accumulated Expenses shows it stood at $254000.0 in 2015, then sank by 81.5% to $47000.0 in 2016, then sank by 85.11% to $7000.0 in 2017, then soared by 485.71% to $41000.0 in 2018, then slumped by 87.8% to $5000.0 in 2019.
- Business Quant data shows SVRA's Other Accumulated Expenses at $5000.0 in Q2 2019, $41000.0 in Q1 2019, and $41000.0 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Savara | 1.28 Bn | 1.28 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 5,000.00 |
| Mar 31, 2019 | 41,000.00 |
| Dec 31, 2018 | 41,000.00 |
| Dec 31, 2017 | 7,000.00 |
| Jun 30, 2017 | 11,000.00 |
| Mar 31, 2017 | 253,000.00 |
| Dec 31, 2016 | 47,000.00 |
| Sep 30, 2016 | 302,000.00 |
| Jun 30, 2016 | 337,000.00 |
| Mar 31, 2016 | 438,000.00 |
| Dec 31, 2015 | 254,000.00 |
| Sep 30, 2015 | 350,000.00 |
| Jun 30, 2015 | 436,000.00 |
| Mar 31, 2015 | 347,000.00 |
| Dec 31, 2014 | 242,000.00 |
| Sep 30, 2014 | 257,213.00 |
| Jun 30, 2014 | 215,582.00 |
| Mar 31, 2014 | 95,544.00 |
| Dec 31, 2013 | 221,000.00 |
| Sep 30, 2013 | 325,944.00 |